Jeff chairs Mintz Levin's Life Sciences Practice. He served as President and Chief Executive Officer of the firm from 1994 to 1996. Jeff has been an active participant and leader in the biotechnology industry since its inception in the late 1970s. He was involved in the formation of some of the earliest companies, and the structuring and negotiation of some of the industry’s earliest strategic alliances, venture financings, and public offerings, and has led Mintz Levin’s Life Sciences group to become one of the largest and best-known in the country.
His clients range in size from newly formed start-up ventures to substantial public companies. He assists these companies with a range of transactions, both domestic and international, including private and public finance, mergers and acquisitions, strategic alliances and joint ventures, and technology transfer and cross-transfer agreements, as well as providing general legal advice, and he has successfully structured, coordinated, and negotiated technology-based transactions with numerous worldwide pharmaceutical and chemical companies. His clients often think of him as an extra member of the executive management team.
Jeff is a frequent lecturer for the Biotechnology Industry Organization, the American Law Institute, and the Massachusetts Continuing Legal Education Foundation, as well as at numerous symposia on biotechnology strategic alliances.
Recognitions & Awards
- Chambers USA: Massachusetts (Band 1) – Corporate/Mergers & Acquisitions (2004 – 2013)
- Chambers USA: Nationwide (Band 1) – Life Sciences: Corporate/Commercial (2007 – 2013)
- Best Lawyers in America: Biotechnology Law, Corporate Law, Mergers & Acquisitions Law (2006 – 2013)
- Boston Best Lawyers Biotechnology Lawyer of the Year (2013)
- Massachusetts Super Lawyers: Business/Corporate (2004 – 2012)
- Martindale-Hubbell AV Preeminent
- “Life Science Star," LMG Life Sciences 2012
Professional & Community Involvement
- Past general counsel, Massachusetts Biotechnology Council
- Member, Advisory Council of the Harvard-MIT Division of Health Sciences and Technology (HST)
- Board member, HST Biomedical Enterprise Program
- Board member, Biomedical Science Careers Program
- Member, Licensing Executives Society
- Member, American Bar Association
- Member, Massachusetts Bar Association
- Member, Boston Bar Association
Jeff chairs Mintz Levin's Life Sciences Practice. He served as President and Chief Executive Officer of the firm from 1994 to 1996. Jeff has been an active participant and leader in the biotechnology industry since its inception in the late 1970s. He was involved in the formation of some of the earliest companies, and the structuring and negotiation of some of the industry’s earliest strategic alliances, venture financings, and public offerings, and has led Mintz Levin’s Life Sciences group to become one of the largest and best-known in the country.
His clients range in size from newly formed start-up ventures to substantial public companies. He assists these companies with a range of transactions, both domestic and international, including private and public finance, mergers and acquisitions, strategic alliances and joint ventures, and technology transfer and cross-transfer agreements, as well as providing general legal advice, and he has successfully structured, coordinated, and negotiated technology-based transactions with numerous worldwide pharmaceutical and chemical companies. His clients often think of him as an extra member of the executive management team.
Jeff is a frequent lecturer for the Biotechnology Industry Organization, the American Law Institute, and the Massachusetts Continuing Legal Education Foundation, as well as at numerous symposia on biotechnology strategic alliances.
Recognitions & Awards
- Chambers USA: Massachusetts (Band 1) – Corporate/Mergers & Acquisitions (2004 – 2013)
- Chambers USA: Nationwide (Band 1) – Life Sciences: Corporate/Commercial (2007 – 2013)
- Best Lawyers in America: Biotechnology Law, Corporate Law, Mergers & Acquisitions Law (2006 – 2013)
- Boston Best Lawyers Biotechnology Lawyer of the Year (2013)
- Massachusetts Super Lawyers: Business/Corporate (2004 – 2012)
- Martindale-Hubbell AV Preeminent
- “Life Science Star," LMG Life Sciences 2012
Professional & Community Involvement
- Past general counsel, Massachusetts Biotechnology Council
- Member, Advisory Council of the Harvard-MIT Division of Health Sciences and Technology (HST)
- Board member, HST Biomedical Enterprise Program
- Board member, Biomedical Science Careers Program
- Member, Licensing Executives Society
- Member, American Bar Association
- Member, Massachusetts Bar Association
- Member, Boston Bar Association
Speaking Engagements
Newsroom
-
Forty-Seven Mintz Levin Attorneys Featured in Chambers USA 2013 Guide, ()
-
Seventy-One Mintz Levin Attorneys Named 2012 Massachusetts Super Lawyers and Rising Stars , ()
-
Mintz Levin Attorney Jeffrey M. Wiesen Named Best Lawyers’Boston Biotechnology Law “Lawyer of the Year”, ()
-
Sixty Mintz Levin Attorneys Included in The Best Lawyers in America, 2013 Edition, ()
-
Mintz Levin’s Jeffrey M. Wiesen Recognized by LMG Life Sciences Named a Life Sciences Star, ()
-
Forty-One Mintz Levin Attorneys Featured in Chambers USA 2012 Guide, ()
-
Fifty-Two Mintz Levin Attorneys Recognized as Massachusetts Super Lawyers, ()
-
Forty-Three Mintz Levin Attorneys Included in The Best Lawyers in America, 2012 Edition, ()
-
Thirty Four Mintz Levin Attorneys Featured in Chambers USA 2011 Guide, ()
-
Forty-Nine Mintz Levin Attorneys Recognized as Massachusetts Super Lawyers, ()
-
Thirty-Nine Mintz Levin Attorneys Included in The Best Lawyers in America, 2011 Edition, ()
-
Mintz Levin Adds Six Attorneys to Chambers USA 2010 Guide, ()
-
Forty-Eight Mintz Levin Attorneys Recognized as Massachusetts Super Lawyers, ()
-
Thirty-One Mintz Levin Attorneys Included in The Best Lawyers in America, 2010 Edition, ()
-
Chambers USA Names 22 Mintz Levin Attorneys Leaders in Their Fields for 2009, ()
-
Twenty-Nine Mintz Levin Attorneys Included in The Best Lawyers in America, 2009 Edition, ()
-
Forty-Six Mintz Levin Attorneys Recognized as Massachusetts Super Lawyers, ()
-
Chambers USA Names 20 Mintz Levin Attorneys Leaders in their Fields for 2008, ()
-
Forty-Five Mintz Levin Attorneys Recognized as Massachusetts Super Lawyers, ()
-
Twenty-Four Mintz Levin Attorneys Included in The Best Lawyers in America, 2008 Edition, ()
-
Chambers USA Names 19 Mintz Levin Attorneys Leaders in Their Fields for 2007, ()
-
Mintz Levin Advises Chiasma, Inc. in $44 Million Series C Financing, ()